Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Vivione Biosciences Inc V.VBI.H

Vivione Biosciences Inc. is a holding company which is currently reviewing potential acquisitions. The Company’s subsidiary is Vivione Biosciences, LLC.


TSXV:VBI.H - Post by User

Vivione Biosciences Inc > PROMOTION
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(11)
•••
Comment by zenvestingon Feb 27, 2015 12:23am
133 Views
Post# 23470821

RE:RE:PROMOTION

RE:RE:PROMOTIONThe CDC has a $20M prize for the development of a rapid point of care test for antibiotic resistant bacteria......I would think VBI's technology has a pretty good lead in the race to develop a rapid point of care test.

NIH Statement of Prize
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities